Page 8 - தசைக்கூட்டு கோளாறுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MENA Biologics & Biosimilars Market to Surpass US$ 623 7 by 2027, Says Coherent Market Insights (CMI)

US$ 442.5 million in 2020 and is expected to exhibit a CAGR of 3.9% during the forecast period (2020-2027). Key Trends and Analysis: The MENA biologics & biosimilars market is expected to witness significant growth, owing to increasing prevalence of Age-related Macular Degeneration (AMD). For instance, according to the study in Saudi Medical Journal 2015, in Saudi Arabia, AMD represents 3.3% of the major causes of blindness in individuals older than 50 years. The increasing approval and new drug launches are expected to propel the market growth. For instance, in 2017, Swedish Orphan Biovitrum AB (Sobi) received Saudi Food & Drug Authority (SFDA) approval for Elocta (efmoroctocog alfa), a recombinant human factor VIII Fc-fusion protein with an extended half-life, for the treatment of hemophilia A.

United statesUnited kingdomWorld health organizationAl qahirahSaudi arabiaAsia pacificChugai pharmaceutical co ltdMinistry of health prevention moRegeneron pharmaceuticals incSaudi food drug authorityTakeda pharmaceutical companyPfizer incAmgen incRoche groupBusiness developmentCoherent market insights

Pharmaceutical Drug Delivery Market Size - Industry Statistics, Share, Analysis and Global Research Report, 2020-2027 | Bayer AG, GlaxoSmithKline PLC, Becton, Dickinson and Company, Novartis AG, etc

Pharmaceutical Drug Delivery Market Size - Industry Statistics, Share, Analysis and Global Research Report, 2020-2027 | Bayer AG, GlaxoSmithKline PLC, Becton, Dickinson and Company, Novartis AG, etc
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.

United statesJohn watsonAsia pacificRoche ltdBayer agMerck coRoute of administration outlook revenueCompany profilesSee campaignResearch newswireAntares pharma incPfizers incJohnson services incHead of business developmentPharmaceutical drug deliveryLatin america

The Worldwide Foot and Ankle Devices Industry is Projected to Reach $5 3 Billion by 2025

Share this article Share this article ResearchAndMarkets.com s offering. The foot and ankle devices market is projected to reach USD 5.3 billion by 2025 from USD 3.9 billion in 2020, at a CAGR of 6.4% during the forecast period. Growth of the market is mainly attributed to the technological advancements; increasing incidences of orthopedic diseases, and growing public and private investments, funding, and grants are driving the global foot and ankle devices market. However, complex regulatory frameworks that delay the approval of new foot and ankle devices is expected to challenge market growth to a certain extent. In terms of products, orthopedic implants and devices segment to register significant growth during the forecast period.

United statesUnited kingdomAsia pacificLaura woodOther companiesOrthopaedic solutionsTennessee incDynamic companiesStryker corporationDynamic response energyKgaaa part of ottobock group scandinaviaProgressive companiesZimmer biomet holdings incCustom researchOttobock se coRehabilitation centers

Regenerative Medicine Market Size Worth $23 57 Bn By 2027; High demand for 3D bioprinting of tissues and organs to better understand their mechanism is driving revenue growth of this segment currently | Reports and Data

Home / Top News / Regenerative Medicine Market Size Worth $23.57 Bn By 2027; High demand for 3D bioprinting of tissues and organs to better understand their mechanism is driving revenue growth of this segment currently | Reports and Data Regenerative Medicine Market Size Worth $23.57 Bn By 2027; High demand for 3D bioprinting of tissues and organs to better understand their mechanism is driving revenue growth of this segment currently | Reports and Data Key participants include MiMedx Group, Inc., Merck & Co., Inc., Integra LifeSciences Corporation, Pfizer Inc., F. Hoffmann-La Roche Ltd., AstraZeneca, Smith & Nephew Plc, Stryker Corporation, Amgen, Inc., and 3M Group, among others. New York, Jan. 18, 2021 (GLOBE NEWSWIRE)

New yorkUnited statesSaudi arabiaSouth koreaAsia pacificRoche ltdHm groupGene expression marketby product and services equipmentStryker corporationMerck co incPfizer incAmgen incMimedx group incSmith nephew plcIntegra lifesciences corporationHead of business development

Cold Pain Therapy Market is expected to see growth rate of 4 5% and may see market size of USD2 4 Billion by 2024

Cold Pain Therapy Market is expected to see growth rate of 4.5% and may see market size of USD2.4 Billion by 2024

United statesUnited kingdomBaden wubergSouth koreaMedline industries united statesResearch mediaPerformance health united statesUnexo life sciences indiaResearch developmentSee campaignResearch newswireHealth hazardsRomsons group of industries indiaMarket research industryCold pain therapy market reportGlobal cold pain therapy